ET
Edward Tenthoff Piper Sandler Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
28
Avg Return
Past Year
Past Year
121%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
100%
Neutral
0%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Reiterated
| $12 |
33%
upside
| 1 | -10% |
0
%
| 4 Mar ‘26 14 hours ago |
|
|
|
Overweight
Maintained
| $6 |
203%
upside
| 1 | +16% |
0
%
| 25 Feb ‘26 7 days ago |
|
|
|
Overweight
Reiterated
| $20 |
45%
upside
| 1 | +41% |
0
%
| 25 Feb ‘26 7 days ago |
|
|
|
Overweight
Maintained
| $69 |
19%
upside
| 1 | +69% |
0
%
| 23 Feb ‘26 9 days ago |
|
|
|
Overweight
Maintained
| $4 |
65%
upside
| 1 | +142% |
0
%
| 20 Jan ‘26 1 month ago |
|
|
|
Overweight
Reiterated
| $37 |
99%
upside
| 1 | -22% |
0
%
| 14 Jan ‘26 1 month ago |
|
|
|
Overweight
Reiterated
| $110 |
69%
upside
| 2 | +20% |
0
%
| 13 Jan ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $8 |
373%
upside
| 1 | -12% |
0
%
| 9 Jan ‘26 1 month ago |
|
|
|
Overweight
Reiterated
| $45 |
76%
upside
| 1 | -6.9% |
0
%
| 10 Dec ‘25 2 months ago |
|
|
|
Overweight
Reiterated
| $125 |
45%
upside
| 1 | -8.7% |
0
%
| 9 Dec ‘25 2 months ago |
|
|
|
Overweight
Reiterated
| $23 |
175%
upside
| 1 | +8.2% |
0
%
| 8 Dec ‘25 2 months ago |
|